NEW YORK (GenomeWeb News) — Researchers working with biomarkers may soon see a new set of guidelines that will cover how biomarkers should be used in clinical trials, the America Association for Cancer Research said last week.
 
The guidelines will be co-developed by the National Cancer Institute, the US Food and Drug Administration, the AACR, and a group of representatives from academia, industry, and patient advocates, as part of a group dubbed the Cancer Biomarker's Collaborative.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.